Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic KidneyÂ Disease
Spironolactone for Heart Failure with Preserved Ejection Fraction
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Spironolactone Use and Improved Outcomes in Patients With Heart Failure With Preserved Ejection Fraction With Resistant Hypertension
Spironolactone Reduces the Risk of Death in Veterans With Heart Failure With Preserved Ejection Fraction
